Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 270-278

  Panchanathan, Ravichandran ^a,b   Liu, Hongzhu ^a   Liu, Hongqi ^a   Fang, Chee Mun ^b   Erickson, Loren D ^d   Pitha, Paula M ^c   Choubey, Divaker ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; PROTEIN P202; UNCLASSIFIED DRUG;

AIM2 GENE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FCGR2B GENE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; IFI202 GENE; IRF5 GENE; MALE; MOUSE; NBA2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON REGULATORY FACTORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; RECEPTORS, IGG; TRANSCRIPTION FACTORS;

EID: 84855368604     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102311     Document Type: Article

References (53)

1. Moser, K. L., J. A. Kelly, C. J. Lessard, and J. B. Harley. 2009. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10: 373-379.
2. Gateva, V., J. K. Sandling, G. Hom, K. E. Taylor, S. A. Chung, X. Sun, W. Ortmann, R. Kosoy, R. C. Ferreira, G. Nordmark, et al. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41: 1228-1233.
3. -/-mouse models of systemic lupus erythematosus. J. Immunol. 184: 796-806.
4. Lien, C., C. M. Fang, D. Huso, F. Livak, R. Lu, and P. M. Pitha. 2010. Critical role of IRF-5 in regulation of B-cell differentiation. Proc. Natl. Acad. Sci. USA 107: 4664-4668.
5. Savitsky, D. A., H. Yanai, T. Tamura, T. Taniguchi, and K. Honda. 2010. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl. Acad. Sci. USA 107: 10154-10159.
6. Beal, E. 2010. IRF5 and B cells in LUPUS development. Nat. Rev. Rheumatol. 6: 437.
7. Tada, Y., S. Kondo, S. Aoki, S. Koarada, H. Inoue, R. Suematsu, A. Ohta, T. W. Mak, and K. Nagasawa. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum. 63: 738-748.
8. Barnes, B., B. Lubyova, and P. M. Pitha. 2002. On the role of IRF in host defense. J. Interferon Cytokine Res. 22: 59-71. (Pubitemid 34161283)
9. Kozyrev, S. V., and M. E. Alarcon-Riquelme. 2007. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40: 591-601. (Pubitemid 350302184)
10. Paun, A., J. T. Reinert, Z. Jiang, C. Medin, M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha. 2008. Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 283: 14295-14308.
11. Shen, H., R. Panchanathan, P. Rajavelu, X. Duan, K. A. Gould, and D. Choubey. 2010. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J. Mol. Cell. Biol. 2: 284-290.
12. Martins, G., and K. Calame. 2008. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26: 133-169. (Pubitemid 351600373)
13. Kuo, T. C., and K. L. Calame. 2004. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J. Immunol. 173: 5556-5563. (Pubitemid 39392142)
14. Doody, G. M., M. A. Care, N. J. Burgoyne, J. R. Bradford, M. Bota, C. Bonifer, D. R. Westhead, and R. M. Tooze. 2010. An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res. 38: 5336-5350.
15. Deng, Y., and B. P. Tsao. 2010. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 6: 683-692.
16. Fensterl, V., and G. C. Sen. 2009. Interferons and viral infections. Biofactors 35: 14-20.
17. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
18. Rönnblom, L., G. V. Alm, and M. L. Eloranta. 2011. The type I interferon system in the development of lupus. Semin. Immunol. 23: 113-121.
19. Sen, G. C., and P. Lengyel. 1992. The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem. 267: 5017-5020.
20. Crow, M. K., and J. Wohlgemuth. 2003. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 5: 279-287. (Pubitemid 37407977)
21. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392. (Pubitemid 44354221)
22. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197: 777-788. (Pubitemid 36350872)
23. Niewold, T. B., J. A. Kelly, M. H. Flesch, L. R. Espinoza, J. B. Harley, and M. K. Crow. 2008. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 58: 2481-2487.
24. Vyse, T. J., S. J. Rozzo, C. G. Drake, S. Izui, and B. L. Kotzin. 1997. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J. Immunol. 158: 5566-5574. (Pubitemid 127681268)
25. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
26. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172. (Pubitemid 24311970)
27. Wither, J. E., A. D. Paterson, and B. Vukusic. 2000. Genetic dissection of B cell traits in New Zealand Black mice: the expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2. Eur. J. Immunol. 30: 356-365. (Pubitemid 30098827)
28. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15: 435-443. (Pubitemid 32907390)
29. Xiu, Y., K. Nakamura, M. Abe, N. Li, X. S. Wen, Y. Jiang, D. Zhang, H. Tsurui, S. Matsuoka, Y. Hamano, et al. 2002. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. 169: 4340-4346. (Pubitemid 35178207)
30. Wither, J. E., G. Lajoie, S. Heinrichs, Y. C. Cai, N. Chang, A. Ciofani, Y. H. Cheung, and R. MacLeod. 2003. Functional dissection of lupus susceptibility loci on the New Zealand Black mouse chromosome 1: evidence for independent genetic loci affecting T and B cell activation. J. Immunol. 171: 1697-1706. (Pubitemid 36966452)
31. Wandstrat, A. E., C. Nguyen, N. Limaye, A. Y. Chan, S. Subramanian, X. H. Tian, Y. S. Yim, A. Pertsemlidis, H. R. Garner, Jr., L. Morel, and E. K. Wakeland. 2004. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21: 769-780. (Pubitemid 39626668)
32. Jørgensen, T. N., J. Alfaro, H. L. Enriquez, C. Jiang, W. M. Loo, S. Atencio, M. R. Bupp, C. M. Mailloux, T. Metzger, S. Flannery, et al. 2010. Development of murine lupus involves the combined genetic contribution of the SLAM and FcγR intervals within the Nba2 autoimmune susceptibility locus. J. Immunol. 184: 775-786.
33. Choubey, D., and B. L. Kotzin. 2002. Interferon-inducible p202 in the susceptibility to systemic lupus. Front. Biosci. 7: e252-e262.
34. Choubey, D., and R. Panchanathan. 2008. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol. Lett. 119: 32-41.
35. Jørgensen, T. N., E. Roper, J. M. Thurman, P. Marrack, and B. L. Kotzin. 2007. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 X NZW)F1 mice. Genes Immun. 8: 653-662. (Pubitemid 350238435)
36. Panchanathan, R., X. Duan, H. Shen, V. A. K. Rathinam, L. D. Erickson, K. A. Fitzgerald, and D. Choubey. 2010. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J. Immunol. 185: 7385-7393.
37. Choubey, D., X. Duan, E. Dickerson, L. Ponomareva, R. Panchanathan, H. Shen, and R. Srivastava. 2010. Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J. Interferon Cytokine Res. 30: 371-380.
38. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
39. Fernandes-Alnemri, T., J. W. Yu, P. Datta, J. Wu, and E. S. Alnemri. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
40. Rathinam, V. A., Z. Jiang, S. N. Waggoner, S. Sharma, L. E. Cole, L. Waggoner, S. K. Vanaja, B. G. Monks, S. Ganesan, E. Latz, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11: 395-402.
41. Panchanathan, R., H. Shen, M. G. Bupp, K. A. Gould, and D. Choubey. 2009. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J. Immunol. 183: 7031-7038.
42. Panchanathan, R., H. Shen, X. Duan, V. A. Rathinam, L. D. Erickson, K. A. Fitzgerald, and D. Choubey. 2011. Aim2 deficiency in mice suppresses the expression of the inhibitory Fcγ receptor (FcγRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J. Immunol. 186: 6762-6770.
43. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7: 335-339. (Pubitemid 126426665)
44. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675. (Pubitemid 30412772)
45. Choubey, D., and P. Lengyel. 1993. Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J. Interferon Res. 13: 43-52. (Pubitemid 23078365)
46. Roberts, T. L., A. Idris, J. A. Dunn, G. M. Kelly, C. M. Burnton, S. Hodgson, L. L. Hardy, V. Garceau, M. J. Sweet, I. L. Ross, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057-1060.
47. Choubey, D. 2000. P202: an interferon-inducible negative regulator of cell growth. J. Biol. Regul. Homeost. Agents 14: 187-192.
48. Panchanathan, R., H. Xin, and D. Choubey. 2008. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice. J. Immunol. 180: 5927-5934.
49. Choubey, D., J. Snoddy, V. Chaturvedi, E. Toniato, G. Opdenakker, A. Thakur, H. Samanta, D. A. Engel, and P. Lengyel. 1989. Interferons as gene activators: indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J. Biol. Chem. 264: 17182-17189. (Pubitemid 19255549)
50. Xin, H., S. D'Souza, T. N. Jørgensen, A. T. Vaughan, P. Lengyel, B. L. Kotzin, and D. Choubey. 2006. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J. Immunol. 176: 5863-5870.
51. Guikema, J. E., C. E. Schrader, M. H. Brodsky, E. K. Linehan, A. Richards, N. El Falaky, D. H. Li, H. K. Sluss, E. Szomolanyi-Tsuda, and J. Stavnezer. 2010. p53 represses class switch recombination to IgG2a through its antioxidant function. J. Immunol. 184: 6177-6187.
52. Xiang, Z., A. J. Cutler, R. J. Brownlie, K. Fairfax, K. E. Lawlor, E. Severinson, E. U. Walker, R. A. Manz, D. M. Tarlinton, and K. G. C. Smith. 2007. FcγRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8: 419-429. (Pubitemid 46745417)
53. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.